Serum interleukin 1, 6, 10 in patients with acute coronary syndromes.
急性冠脉综合征患者血清白介素1,6,10的变化。
Methods One hundred and ten patients with NACS and 110 patients with acute coronary syndromes (ACS) were enrolled.
方法选择病情稳定的冠心病(NACS)患者和急性冠脉综合征(ACS)患者各110例。
Pregnancy associated plasma protein-A (PAPP-A) has recently been shown to be associated with acute coronary syndromes (ACS).
近来发现妊娠相关性血浆蛋白- A (PAPP - A)与急性冠状动脉综合征(ACS)有关。
What is your opinion about distal embolic protection and embolic-protection devices during PCI for patients with acute coronary syndromes?
如何看待远端保护装置和血栓抽吸装置在急性冠脉综合症患者PCI期间的应用？
Objective To study the changes of the endothelial tissue plasminogen activator reserve capacity in patients with acute coronary syndromes.
目的探讨急性冠状动脉综合征患者内皮组织纤溶酶原激活剂储备功能的变化规律。
Objective To evaluate the level of T-lymphocyte subpopulations in blood of senior citizen with acute coronary syndromes (ACS) when the disease occurred.
目的探讨老年急性冠脉综合征(ACS)患者血外周血t淋巴细胞亚群水平变化与发病关系。
The similar distribution of culprit arteries was observed in the most of reviewed published studies involving the patients with acute coronary syndromes.
在大多数已发布的关于急性冠脉综合症的研究中，上述病变血管的分布是相似的。
Background Earlier trials have shown that a routine invasive strategy improves outcomes in patients with acute coronary syndromes without ST-segment elevation.
早期临床试验表明常规介入治疗可改善ST段抬高型急冠脉综合征病人预后。
Objective To observe the levels of platelet alpha-granule membrane glycoprotein 140 (GMP-140) and fibrinopeptide a (FPA) in patients with acute coronary syndromes (ACS).
目的观察急性冠状动脉综合征(ACS)患者血浆血小板膜糖蛋白140 (GMP- 140)及纤维蛋白肽a (FPA)水平的改变。
Objectives: This study sought to investigate potential protective effects of atorvastatin in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI).
目的：本研究旨在探索阿托伐他汀对急性冠脉综合征(ACS)患者行经皮冠脉介入治疗(pci)潜在的保护作用。
NEW DATA showing increased mortality rates associated with drug eluting stents (DES) in acute coronary syndromes were presented in a Hot Line Session yesterday.
昨日一个热点会议发布，新的研究数据表明与药物洗脱支架(DES)有关的急性冠状动脉综合征死亡率不断增加。
Background Despite current treatment, patients who have acute coronary syndromes without ST-segment elevation associated with t 2 Diabetes have high rates of major vascular events.
背景合并2型糖尿病的非st段抬高的急性冠脉综合征病人，无论用当前任何治疗方法，都有较高的大血管事件发生率。
BACKGROUND Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis.
背景急性冠脉综合征由冠状动脉粥样硬化叠加血栓形成引起。
Objective to determine that atorvastatin might have anti-inflammatory effects in acute coronary syndromes (ACS) with C-reactive protein (CRP) reduction.
目的探讨阿托伐他汀可通过降低急性冠脉综合征(ACS)的C -反应蛋白(CRP)水平而发挥抗炎效应。
Objectives: the goal of this work was to explore the treatment and outcomes of patients with non-st-segment elevation acute coronary syndromes (NSTE-ACS) age 90 years.
目的：本研究旨在探讨90岁以上非st段抬高急性冠脉综合征(NSTE - ACS)患者的治疗措施及预后。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
应用推荐